InvestorsHub Logo
Post# of 253253
Next 10
Followers 839
Posts 120509
Boards Moderated 18
Alias Born 09/05/2002

Re: genisi post# 112541

Wednesday, 01/19/2011 6:18:25 PM

Wednesday, January 19, 2011 6:18:25 PM

Post# of 253253
MRK/Vorapaxar—Intracranial hemorrhage confirmed as the reason for terminating the TRACER study and restricting the patient pool in the TRA-2P study:

http://finance.yahoo.com/news/Merck-Says-Additional-bw-2661003325.html?x=0&.v=1

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.